FDA Inspection
Bioreliance Ltd.Bioreliance Ltd. – FDA Inspection, Sep 22, 2017
Record Details
This FDA Inspection record concerns Bioreliance Ltd., with an inspection on September 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a56f5793-c36b-4041-8038-c123cd545822
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026860
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bioreliance Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2025 | Not classified | Office of Inspections and Investigations | |
| November 7, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 17, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Bioreliance Ltd.
- FDA Inspection 1288500 - 2025-12-05
- FDA Inspection 1225550 - 2023-11-07
- FDA Inspection 1202961 - 2021-03-17
- FDA Inspection 1108960 - 2019-09-27
- FDA Inspection 1093195 - 2019-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.